HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xi Huang Selected Research

qiangxin fumai

1/2008[Effect of Qiangxin Fumai granule on myocyte apoptosis of sinus node and Bax, Bcl-2, Fas-L gene protein in rabbits of sinoatrial ischemia/reperfusion].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xi Huang Research Topics

Disease

54Neoplasms (Cancer)
01/2022 - 12/2003
41Infections
07/2022 - 06/2002
26Inflammation (Inflammations)
08/2022 - 11/2002
16Keratitis
01/2021 - 08/2003
14Carcinogenesis
01/2022 - 12/2003
11COVID-19
01/2022 - 01/2020
9Multiple Myeloma
01/2022 - 11/2017
8Insulin Resistance
01/2021 - 06/2010
8Traumatic Brain Injuries (Traumatic Brain Injury)
01/2021 - 09/2012
8Breast Neoplasms (Breast Cancer)
12/2019 - 08/2008
8Hypoxia (Hypoxemia)
01/2016 - 12/2003
8Iron Overload
04/2015 - 01/2002
7Infarction (Infarctions)
12/2022 - 10/2007
7Neoplasm Metastasis (Metastasis)
02/2021 - 06/2013
7Wounds and Injuries (Trauma)
01/2021 - 04/2004
7Atherosclerosis
01/2020 - 11/2006
6Tuberculosis (Tuberculoses)
01/2021 - 06/2015
6Medulloblastoma
01/2020 - 10/2010
6Myocardial Infarction
01/2017 - 12/2008
5Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2016
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 06/2010
5Alzheimer Disease (Alzheimer's Disease)
12/2021 - 01/2018
5Virus Diseases (Viral Diseases)
11/2021 - 01/2011
5Brain Neoplasms (Brain Tumor)
01/2021 - 09/2015
5Lung Diseases (Lung Disease)
01/2021 - 03/2002
5Dyspepsia (Indigestion)
06/2019 - 05/2006
5Osteoporosis
04/2015 - 06/2011
5Pancreatitis
01/2014 - 03/2005
5Anthracosis
03/2013 - 09/2002
4Obesity
10/2022 - 01/2018
4Atherosclerotic Plaque (Atheroma)
01/2022 - 07/2019
4Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2011
4Cognitive Dysfunction
01/2022 - 01/2020
4Mitochondrial Diseases (Mitochondrial Disease)
12/2021 - 01/2020
4Necrosis
12/2021 - 11/2006
4Brain Edema (Cerebral Edema)
01/2020 - 11/2016
4Corneal Diseases (Corneal Disease)
12/2013 - 01/2006
4Iron Deficiencies
06/2013 - 08/2008
3Nervous System Diseases (Neurological Disorders)
12/2022 - 10/2018
3Hypertension (High Blood Pressure)
10/2022 - 06/2013
3Edema (Dropsy)
01/2022 - 06/2016
3Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 01/2018
3Lung Neoplasms (Lung Cancer)
01/2021 - 02/2009
3Peripheral Nervous System Diseases (PNS Diseases)
11/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2002
26IronIBA
06/2014 - 01/2002
19CytokinesIBA
01/2020 - 11/2002
17Pharmaceutical PreparationsIBA
12/2021 - 10/2007
13Biomarkers (Surrogate Marker)IBA
03/2021 - 01/2004
11Interleukin-6 (Interleukin 6)IBA
12/2022 - 10/2004
11Messenger RNA (mRNA)IBA
02/2021 - 07/2005
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 08/2008
9Biological ProductsIBA
10/2021 - 01/2002
8Caspase 3 (Caspase-3)IBA
11/2020 - 10/2007
8EnzymesIBA
10/2020 - 04/2004
8Coal (Coals)IBA
03/2013 - 03/2002
7ferulic acid (sodium ferulate)IBA
01/2022 - 05/2006
7Glucose (Dextrose)FDA LinkGeneric
12/2021 - 06/2010
7LipidsIBA
01/2020 - 09/2007
7Ferritins (Ferritin)IBA
01/2014 - 09/2002
6Ion Channels (Ion Channel)IBA
01/2022 - 08/2012
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 06/2002
6Small Interfering RNA (siRNA)IBA
01/2018 - 11/2005
5RNA (Ribonucleic Acid)IBA
01/2022 - 06/2015
5Antiviral Agents (Antivirals)IBA
11/2021 - 01/2017
5DNA (Deoxyribonucleic Acid)IBA
10/2021 - 01/2015
5Triglycerides (Triacylglycerol)IBA
12/2019 - 06/2010
5LigandsIBA
05/2019 - 01/2011
5Transcription Factors (Transcription Factor)IBA
01/2018 - 11/2002
5Toll-Like Receptors (Toll-Like Receptor)IBA
02/2013 - 11/2005
4Neuroprotective AgentsIBA
12/2022 - 01/2016
4C-Reactive ProteinIBA
01/2022 - 11/2006
4VaccinesIBA
12/2021 - 01/2015
4AntibodiesIBA
12/2021 - 06/2008
4Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 04/2011
4meranzin hydrateIBA
01/2021 - 09/2011
4NF-kappa B (NF-kB)IBA
01/2021 - 01/2010
3Therapeutic UsesIBA
08/2022 - 01/2018
3CaspasesIBA
01/2022 - 09/2018
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2022 - 01/2018
3Bortezomib (Velcade)FDA Link
01/2022 - 01/2018
3Immunoglobulins (Immunoglobulin)IBA
01/2022 - 10/2019
3ChromatinIBA
01/2022 - 01/2017
3Peptides (Polypeptides)IBA
12/2021 - 06/2015
3EpitopesIBA
12/2021 - 01/2015
3hydroxysafflor yellow AIBA
01/2021 - 01/2011
3AntioxidantsIBA
01/2021 - 09/2012
3Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 07/2019
3NAD (NADH)IBA
11/2020 - 01/2020
3Amyloid (Amyloid Fibrils)IBA
11/2020 - 01/2018
3peoniflorinIBA
01/2020 - 01/2011
3p38 Mitogen-Activated Protein KinasesIBA
01/2020 - 10/2004
3Potassium Channels (Potassium Channel)IBA
01/2020 - 07/2014
3danggui buxue decoctionIBA
01/2020 - 11/2006
3Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 01/2017
3CateninsIBA
01/2020 - 12/2013

Therapy/Procedure

20Therapeutics
01/2022 - 01/2002
7Oral Administration
06/2019 - 01/2009
5Drug Therapy (Chemotherapy)
07/2021 - 01/2017
5Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 03/2005